Yazdanpanah, Z., Azadi-Yazdi, M., Hooshmandi, H., Ramezani-Jolfaie, N., & Salehi-Abargouei, A
The gut and beyond: GI effects and other tissues In the gastrointestinal tract, the receptor appears in the Brunners glands of the duodenum, in parietal cells, and in gastric smooth muscle, where it slows gastric emptying
59 Small molecule GLP-1RA in preclinical trials MLX-7005 MLX-7005 is a highly potent, oral small-molecule GLP-1 receptor agonist (GLP-1RA) that robustly activates the GLP-1 receptor cAMP signaling pathway without measurable -arrestin recruitment
GLP-1 contributes to increases in PGC-1 expression by downregulating miR-23a to reduce apoptosis
According to Holst these results meant 'There was no longer any doubt: GLP-1 treatment of type 2 diabetes was extremely promising' (Holst 2024)
78 The half-life of PEG-loxenatide is approximately 1 week